Koch leads mam­moth $215M in­fu­sion in­to AI start­up boast­ing 'largest data­base' of im­mune cells

In the three years since Noam Solomon and Luis Voloch start­ed Im­mu­nai, the com­pa­ny has quick­ly out­grown its digs.

Im­mu­nai’s team went from 30 staffers in May 2020 to 120, rep­re­sent­ing 16 na­tion­al­i­ties and spread across five cities — Tel Aviv, New York, San Fran­cis­co, Zurich and Prague — af­ter re­cent­ly ac­quir­ing two com­pa­nies to beef up their data­base and an­a­lyt­ic ca­pa­bil­i­ties. More than 30 groups in bio­phar­ma and acad­e­mia have signed up to use their tech­nolo­gies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER